These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 23966863)
1. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors. Yamin R; Kaynan NS; Glasner A; Vitenshtein A; Tsukerman P; Bauman Y; Ophir Y; Elias S; Bar-On Y; Gur C; Mandelboim O PLoS Pathog; 2013 Aug; 9(8):e1003568. PubMed ID: 23966863 [TBL] [Abstract][Full Text] [Related]
2. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Weber KS; Gröne HJ; Röcken M; Klier C; Gu S; Wank R; Proudfoot AE; Nelson PJ; Weber C Eur J Immunol; 2001 Aug; 31(8):2458-66. PubMed ID: 11500830 [TBL] [Abstract][Full Text] [Related]
3. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073 [TBL] [Abstract][Full Text] [Related]
4. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. Hudspeth K; Donadon M; Cimino M; Pontarini E; Tentorio P; Preti M; Hong M; Bertoletti A; Bicciato S; Invernizzi P; Lugli E; Torzilli G; Gershwin ME; Mavilio D J Autoimmun; 2016 Jan; 66():40-50. PubMed ID: 26330348 [TBL] [Abstract][Full Text] [Related]
5. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. Endres MJ; Garlisi CG; Xiao H; Shan L; Hedrick JA J Exp Med; 1999 Jun; 189(12):1993-8. PubMed ID: 10377196 [TBL] [Abstract][Full Text] [Related]
6. Role of chemokines in the biology of natural killer cells. Maghazachi AA Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317 [TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor. Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794 [TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. Nakano K; Isegawa Y; Zou P; Tadagaki K; Inagi R; Yamanishi K Arch Virol; 2003 May; 148(5):871-90. PubMed ID: 12721796 [TBL] [Abstract][Full Text] [Related]
9. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Boshoff C; Endo Y; Collins PD; Takeuchi Y; Reeves JD; Schweickart VL; Siani MA; Sasaki T; Williams TJ; Gray PW; Moore PS; Chang Y; Weiss RA Science; 1997 Oct; 278(5336):290-4. PubMed ID: 9323208 [TBL] [Abstract][Full Text] [Related]
10. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1. Davis CN; Zujovic V; Harrison JK Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546 [TBL] [Abstract][Full Text] [Related]
11. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II. Zhou N; Luo Z; Luo J; Hall JW; Huang Z Biochemistry; 2000 Apr; 39(13):3782-7. PubMed ID: 10736178 [TBL] [Abstract][Full Text] [Related]
13. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. Chen S; Bacon KB; Li L; Garcia GE; Xia Y; Lo D; Thompson DA; Siani MA; Yamamoto T; Harrison JK; Feng L J Exp Med; 1998 Jul; 188(1):193-8. PubMed ID: 9653095 [TBL] [Abstract][Full Text] [Related]
14. The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Lüttichau HR; Lewis IC; Gerstoft J; Schwartz TW Eur J Immunol; 2001 Apr; 31(4):1217-20. PubMed ID: 11298347 [TBL] [Abstract][Full Text] [Related]
15. CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure. Shao W; Fernandez E; Sachpatzidis A; Wilken J; Thompson DA; Schweitzer BI; Lolis E Eur J Biochem; 2001 May; 268(10):2948-59. PubMed ID: 11358512 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation. Fernandez EJ; Wilken J; Thompson DA; Peiper SC; Lolis E Biochemistry; 2000 Oct; 39(42):12837-44. PubMed ID: 11041848 [TBL] [Abstract][Full Text] [Related]
17. Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo. Rubant S; Ludwig RJ; Pfeffer J; Schulze-Johann P; Kaufmann R; Pfeilschifter JM; Boehncke WH; Radeke HH Exp Dermatol; 2006 Aug; 15(8):634-42. PubMed ID: 16842602 [TBL] [Abstract][Full Text] [Related]
18. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Stine JT; Wood C; Hill M; Epp A; Raport CJ; Schweickart VL; Endo Y; Sasaki T; Simmons G; Boshoff C; Clapham P; Chang Y; Moore P; Gray PW; Chantry D Blood; 2000 Feb; 95(4):1151-7. PubMed ID: 10666184 [TBL] [Abstract][Full Text] [Related]
19. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Cockwell P; Calderwood JW; Brooks CJ; Chakravorty SJ; Savage CO Nephrol Dial Transplant; 2002 May; 17(5):734-44. PubMed ID: 11981057 [TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of chemokine receptors in human natural killer cells. Inngjerdingen M; Damaj B; Maghazachi AA Blood; 2001 Jan; 97(2):367-75. PubMed ID: 11154210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]